Correlation Between Boundless Bio, and Leap Therapeutics
Can any of the company-specific risk be diversified away by investing in both Boundless Bio, and Leap Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boundless Bio, and Leap Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boundless Bio, Common and Leap Therapeutics, you can compare the effects of market volatilities on Boundless Bio, and Leap Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boundless Bio, with a short position of Leap Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boundless Bio, and Leap Therapeutics.
Diversification Opportunities for Boundless Bio, and Leap Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Boundless and Leap is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Boundless Bio, Common and Leap Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Leap Therapeutics and Boundless Bio, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boundless Bio, Common are associated (or correlated) with Leap Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Leap Therapeutics has no effect on the direction of Boundless Bio, i.e., Boundless Bio, and Leap Therapeutics go up and down completely randomly.
Pair Corralation between Boundless Bio, and Leap Therapeutics
Given the investment horizon of 90 days Boundless Bio, is expected to generate 1810.52 times less return on investment than Leap Therapeutics. But when comparing it to its historical volatility, Boundless Bio, Common is 19.3 times less risky than Leap Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Leap Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Leap Therapeutics on August 22, 2025 and sell it today you would earn a total of 174.00 from holding Leap Therapeutics or generate 561.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 88.64% |
| Values | Daily Returns |
Boundless Bio, Common vs. Leap Therapeutics
Performance |
| Timeline |
| Boundless Bio, Common |
| Leap Therapeutics |
Boundless Bio, and Leap Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Boundless Bio, and Leap Therapeutics
The main advantage of trading using opposite Boundless Bio, and Leap Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boundless Bio, position performs unexpectedly, Leap Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leap Therapeutics will offset losses from the drop in Leap Therapeutics' long position.| Boundless Bio, vs. Q32 Bio | Boundless Bio, vs. NextCure | Boundless Bio, vs. Plus Therapeutics | Boundless Bio, vs. Intensity Therapeutics, Common |
| Leap Therapeutics vs. Citius Pharmaceuticals | Leap Therapeutics vs. Athira Pharma | Leap Therapeutics vs. Curis Inc | Leap Therapeutics vs. Processa Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |